BACKGROUND: To assess the value of positron emission tomography/computed tomography (PET/CT) with 18F-Fluorodeoxyglucose (FDG) in patients with head and neck carcinoma as compared with PET and conventional imaging alone, and to assess the impact of PET/CT on further clinical management. STUDY DESIGN: Prospective nonrandomized study. SETTING: Ninety patients with head and neck tumors had 107 PET/CT examinations. RESULTS: The study analysis showed that PET/CT had a sensitivity of 89%, specificity 95%, PPV 94%, NPV 90%, and accuracy of 92%. PET/CT altered management in 51 patients (56%). PET/CT eliminated the need for previously planned diagnostic procedures in 24 patients, induced a change in the planned therapeutic approach in 21 patients and guided biopsy in 6 patients. CONCLUSIONS: PET/CT is an imaging modality with high diagnostic performance in the assessment of head and neck cancer, and induced a change in further clinical management in more than half of the study population.
BACKGROUND: To assess the value of positron emission tomography/computed tomography (PET/CT) with 18F-Fluorodeoxyglucose (FDG) in patients with head and neck carcinoma as compared with PET and conventional imaging alone, and to assess the impact of PET/CT on further clinical management. STUDY DESIGN: Prospective nonrandomized study. SETTING: Ninety patients with head and neck tumors had 107 PET/CT examinations. RESULTS: The study analysis showed that PET/CT had a sensitivity of 89%, specificity 95%, PPV 94%, NPV 90%, and accuracy of 92%. PET/CT altered management in 51 patients (56%). PET/CT eliminated the need for previously planned diagnostic procedures in 24 patients, induced a change in the planned therapeutic approach in 21 patients and guided biopsy in 6 patients. CONCLUSIONS: PET/CT is an imaging modality with high diagnostic performance in the assessment of head and neck cancer, and induced a change in further clinical management in more than half of the study population.
Authors: Enver Ozer; Barış Naiboğlu; Ryan Meacham; Cherie Ryoo; Amit Agrawal; David E Schuller Journal: Eur Arch Otorhinolaryngol Date: 2012-01-15 Impact factor: 2.503
Authors: V A Passero; B F Branstetter; Y Shuai; D E Heron; M K Gibson; S Y Lai; S W Kim; J R Grandis; R L Ferris; J T Johnson; A Argiris Journal: Ann Oncol Date: 2010-04-29 Impact factor: 32.976
Authors: M E Heft Neal; J Brennan; J C Brenner; A G Shuman; S B Chinn; C L Stucken; K M Malloy; J S Moyer; K A Casper; S A McLean; M E P Prince; C R Bradford; G T Wolf; D B Chepeha; A J Rosko; M E Spector Journal: Ann Surg Oncol Date: 2019-09-19 Impact factor: 5.344
Authors: Shlomo A Koyfman; Nofisat Ismaila; Doug Crook; Anil D'Cruz; Cristina P Rodriguez; David J Sher; Damian Silbermins; Erich M Sturgis; Terance T Tsue; Jared Weiss; Sue S Yom; F Christopher Holsinger Journal: J Clin Oncol Date: 2019-02-27 Impact factor: 44.544
Authors: Dae Young Yoon; Hee Sung Hwang; Suk Ki Chang; Young-Soo Rho; Hwoe Young Ahn; Jin Hwan Kim; In Jae Lee Journal: Eur Radiol Date: 2008-10-09 Impact factor: 5.315
Authors: Klaus Strobel; Stephan K Haerle; Sandro J Stoeckli; Madeleine Schrank; Jan D Soyka; Patrick Veit-Haibach; Thomas F Hany Journal: Eur J Nucl Med Mol Imaging Date: 2009-02-10 Impact factor: 9.236